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Background: Salivary changes in hemodialysis patients may result in various oral manifestations. This research 
intended to determine oral manifestations and some salivary markers in hemodialysis patients. 
Material and Methods: This cross-sectional study was conducted on 30 hemodialysis patients (the patient group) 
and 30 healthy individuals (the control group). Saliva urea and calcium levels and pH values of the participants 
were measured, and oral manifestations such as pale mucosa, xerostomia, halitosis, changes in the sense of taste, 
increased calculus formation, gingival bleeding, etc. were recorded in the information collection form. The data 
was analyzed using T-test and chi-square, and p<0.05 was considered to be significant. 
Results: The mean salivary urea level and pH value in the patient group were significantly higher compared to 
those of the control group (p<0.05), but there were no significant differences between the two groups with respect 
to salivary calcium. Halitosis, xerostomia, and increased calculus were the most prevalent manifestations, and gum 
bleeding was the least prevalent among the patients.    
Conclusions: Advanced chronic renal insufficiency can increase salivary urea level, pH value, halitosis, xerosto-
mia, and calculus formation, and may cause pale mucosa.




There are about 1.8 million patients with end stage renal 
disease (ESRD) in the world that need to treatment, inclu-
ding hemodialysis, peritoneal dialysis, or transplantation 
(1). According to study in 2006, about 12 500 Iranian pa-
tients with ESRD (48.5%) received hemodialysis (2). 
Dialysis treatment leads to systemic changes, oral com-
plications, and changes in salivary flow rate and saliva 
composition (3-5). 
The importance of saliva as a diagnostic fluid has attrac-
ted interest in recent years. The advantages of using sali-
va, which include its easy availability, non-invasiveness, 
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and the close relationship between saliva and serum pa-
rameters, have attracted the interest of researchers in 
saliva as a unique fluid for diagnosing various diseases 
(6,7). 
In research carried out by Kaushik et al. (8) to study 
oral and salivary changes among hemodialysis patients, 
it was found that 65% of the patients exhibited at least 
one of the oral manifestations. The mean stimulated and 
non-stimulated salivary flow rates in these patients were 
significantly lower than those of the control group. Man-
sourian et al. (9) conducted a study to compare prevalen-
ce of oral lesions in kidney transplant and hemodialysis 
patients and noticed there was at least one intraoral lesion 
(including xerostomia, aphthous ulcers, squamous papi-
lloma, gingival inflammation, and candidiasis) in 32.2% 
of kidney transplant and in 8.6% of dialysis patients. The 
most prevalent manifestation was xerostomia (4.3%) in 
dialysis patients, while gingival inflammation (1.1%), 
and candidiasis (2.2%) were of lower prevalence.    
It is necessary to have a thorough knowledge of oral 
manifestations in hemodialysis patients to take neces-
sary precautions for preventing bacteremia and the con-
sequent complications. Considering the increase in the 
number of dialysis patients in Iran (10), and since no 
research had been conducted on hemodialysis patients in 
Zahedan to simultaneously study salivary markers and 
oral manifestations, it was decided to investigate oral 
manifestations and some salivary markers (urea, cal-
cium, and pH) in hemodialysis patients.
Material and Methods
This cross-sectional study was conducted on 30 hemo-
dialysis patients (at the Hemodialysis Ward of Imam Ali 
Hospital in Zahedan) and 30 healthy individuals (the con-
trol group). The inclusion criteria were for the patients to 
be older than 18 years old, had been under hemodialysis 
for more than 1 year, and undergoing hemodialysis in 
three times a week for the period of 2-4 hours.
Exclusion criteria included history of alcohol use, smo-
king, caffeine consumption during the past 24 hours, 
and medical problems except kidney disease (such as 
history of radiotherapy, Sjogren’s syndrome, etc.) and 
medications use that influenced salivary glands and their 
secretion.  
The control group had no history of drug therapy or sys-
temic diseases. Moreover, they were matched to the pa-
tients group with respect to age, gender, and weight. The 
purpose of this study was explained along with informed 
consent taken from all the subjects and Ethics Commit-
tee of Zahedan University of Medical Sciences approval 
taken for this study (No.1051).
Patients received saliva collection tubes before being 
connected to dialysis machines between 9 and 11 in the 
morning (the best time for saliva collection). They were 
asked not to eat, drink, or brush their teeth 90 minutes 
before the saliva samples were taken to prevent any sti-
mulation. The spitting method was employed to collect 
non-stimulated saliva: the participant poured saliva once 
every 60 seconds for 5 minutes into the saliva collection 
tube. The collected saliva samples were kept in sterili-
zed Falcon tubes with their caps in the closed position 
and were then coded and sent to the Biochemistry La-
boratory of Zahedan University of Medical Sciences 
where they were centrifuged at 3500 rpm for 20 minutes 
to separate the debris. The transparent supernatant was 
kept at -20˚C until tests were carried out to measure the 
markers.    
After saliva collection, intraoral examinations were ca-
rried out and the information forms were completed. 
A oral medicine specialist performed the examinations 
using disposable mirrors under the light of a strong flas-
hlight, while the patients lay on their beds with their 
heads at a suitable height.
Oral manifestations included uremic breath that could be 
smelled at a distance of 10 cm from the patients’ mouths 
(11), pale mucosa, increased calculus formation, pete-
chial and purpura, candidiasis, changes in the sense of 
taste, and gingival bleeding. On thorough examination 
of the oral cavity, these manifestations were recorded in 
the questionnaires.  
Xerostomia was investigated objectively using the ton-
gue blade test: adhesion of a standard wooden tongue 
blade to the buccal mucosa indicates the mucosa is not 
sufficiently moistened. Xerostomia was also subjecti-
vely determined when patients complained of difficulty 
in chewing, swallowing, speaking, and overdenture atta-
chment (9). 
Saliva was thawed to measure the biochemical parame-
ters in the study. Calcium was measured by using the O-
cresolphthalein method and urea by using a urease me-
thod based on the protocols of Pars Azmoon Co (Iran), 
and pH by employing an electrical pH meter. The results 
of these experiments were recorded in the information 
forms. 
The data was analyzed using SPSS 16 and frequency 
tables and descriptive statistics, including mean and dis-
persion indices, were employed to describe the data and, 
finally, in depended sample t-test and chi-square were 
used for expressing statistical relationships.
Results
This research intended to determine oral manifestations 
and some salivary markers in hemodialysis patients. For 
this purpose, 30 dialysis patients were selected as the pa-
tient group and 30 of healthy individuals as the control 
group. Seventy percent of the participants were male. 
The average age of the participants was 38.17±16.88 in 
the patient group and 40.30±18.34 in the control group, 
and the mean weight was 70.63±15.31 in the patient 
group and 73.85±18.45 in the control group.  
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As shown in table 1, the mean levels of saliva urea were 
different in the two groups: 125.8±68.33 in the patient 
group and 41.22±16.35 mg/dl in the control group, 
which indicated a significant difference (p=0.0001). 
Furthermore, the mean pH was 8.41±0.76 in the pa-
tient group and 7.01±0.31 in the control group, which 
showed a significant difference between the two groups 
(p=0.042). Moreover, the measured calcium levels were 
2.32±1.15 and 2.47±1.33 mg/dl in the patient and con-
trol groups, respectively, which showed there were no 
significant differences between the two groups in this 
respect (p=0.206).
Table 2 indicates halitosis, increased calculus formation, 
and xerostomia were the most prevalent, and gingival 
bleeding the least frequent oral manifestations in hemo-
dialysis patients. No cases of pale mucosa or gingival 






Salivary  urea(mg/dl) 125.8±68.33 41.22±16.35 0.0001
Salivary calcium(mg/dl) 2.23±1.15 2.47±1.33 0.206
PH 8.41±0.76 7.01±0.31 0.042
*In depended sample t-test.
Table 1. Statistical comparison of mean values between hemodialysis patients and control groups.





Dry mouth 14(46.7) 4(13.3) 0.005
Taste change 13(43.3) 3(10) 0.004
Gingival bleeding 5(16.7) 0 0.02
halitosis 16(53.3) 6(20) 0.007
Calculus information 15(50) 4(13.3) 0.002
Pale mucosae 12(42.2) 0 0.002
*Chi-square test.
Table 2. Comparison of oral manifestations between hemodialysis patients and control groups.
Discussion
This research showed that salivary pH values and urea 
levels (8.41±0.76 and 125.8±68.33, respectively) in 
patients with chronic renal insufficiency were higher 
compared to healthy people, but that there were no sig-
nificant differences between the two groups in mean sa-
livary calcium levels. As for clinical oral manifestations, 
halitosis, xerostomia, and increased calculus formation 
were most prevalent, and gingival bleeding was the least 
prevalent, among hemodialysis patients.  
Increases in urea compounds have been mentioned as 
one of the findings in most studies carried out on renal 
patients (12,13). Based on this research, salivary pH 
values in hemodialysis patients were significantly hig-
her compared to the healthy group (8.41±0.76 versus 
7.01±0.31), and these results are in agreement with that 
found in research conducted by Al Nowaiser et al. (14). 
Salivary urea is decomposed into ammonium ions and 
carbon dioxide by urease and, hence, may raise salivary 
pH to critical values (14). 
Moreover, high salivary urea levels and decomposition 
of urea into ammonia increase halitosis in people with 
kidney diseases. In this research, 53.3% of the patient 
group and 20% of the control group also suffered from 
halitosis. Patil et al. (15) reported 34% of the patients in 
their study were afflicted with halitosis. Another reason 
for increased rates of halitosis could be negligence in 
oral hygiene because of the chronic nature of the disease 
in these people (8). 
Calcium levels in the patient group were lower than 
those of the control group, but these differences were 
not statistically significant. Some studies have referred 
to reduced calcium levels in hemodialysis patients (12). 
Chronic uremia is characterized by decreased levels of 
active metabolites of vitamin D synthesized in the kid-
neys. The consequence is an increased synthesis and 
secretion of parathyroid hormone (secondary hyperpara-
thyroidism) causing to the low levels of calcium (16). 
The prevalence of xerostomia in the patient group 
(46.7%) was significantly higher than that of the control 
group (13.3%). This figure is lower than those reported 
in study conducted by Patil et al. (15) (91%) but almost 
similar to the 43% reported by Kaushik et al. (8). The 
differences between our results and this reported by Patil 
et al. (15) could probably be due to differences between 
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the studied populations (inclusion and exclusion criteria) 
and the different methods used in evaluating xerostomia. 
Xerostomia may be caused by reduced salivary flow rate 
secondary to atrophy and fibrosis of the salivary glands, 
taking special drugs, and limited intake of liquids, in-
creasing age, and oral breathing secondary to Pulmonary 
conditions (17). 
Some of the hemodialysis patients experienced changes 
in the sense of taste (43.3% in the patient group compa-
red to 10% in the control group), and this figure is simi-
lar to those reported by Patil et al. (15) and Bots et al. 
(18) in their studies. Changes in the sense of taste may 
have various reasons such as increased levels of salivary 
urea and dimethyl and trimethylamine levels, metabolic 
disorders, taking medications, reduced number of taste 
buds, changes in salivary flow rate and saliva composi-
tion in uremic patients (8).   
Pale mucosa was another manifestation observed in the 
patient group (42.2%), while no cases of it were seen 
in the control group. In study carried out by Patil et al. 
(15) references were made to pale mucosa. Pale muco-
sa results from anemia mainly developed following the 
inability of the failing kidneys to secrete erythropoietin, 
loss of red blood cells through dialysis, increased brittle-
ness of red blood cells and their early destruction and, in 
some cases, from malnutrition (13). 
Increased calculus formation was observed in 50% and 
13.3% of the patient and control groups, respectively. 
In the study conducted by Martins et al. (7) calculus 
was formed in 75% and 36% of the patient and control 
groups, respectively. Increased salivary urea levels and 
reduced saliva production can facilitate plaque forma-
tion (19).
Gingival bleeding in 16.7% of the members in the pa-
tient group was another finding of this study, but no 
cases of it in the control group. Unnatural bleeding is 
one of the problems associated with dialysis. Intrinsic 
platelet abnormalities and impaired platelet-vessel wall 
interaction are factor responsible for bleeding tenden-
cies in ESRD. Anemia, dialysis, the accumulation of 
medications due to poor clearance, and anticoagulation 
used during dialysis have some role in causing bleeding 
in ESRD patients (20). 
Findings of this research indicate that hemodialysis pa-
tients are at greater risk of developing oral manifesta-
tions, and that it is necessary that these patients be un-
der careful supervision with respect to oral and dental 
hygiene and mucosal manifestations. Moreover, timely 
diagnosis and treatment of oral manifestations will subs-
tantially help improve their life satisfaction. 
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